Today: 22 March 2026
Subscribe
Browse Category

Financial Forecasts 24 December 2025

Micron Technology (MU) Stock Hits Fresh Records on Dec. 24, 2025: AI Memory Crunch, Blowout Guidance, and Wall Street’s Latest Forecasts

Micron Technology (MU) Stock Hits Fresh Records on Dec. 24, 2025: AI Memory Crunch, Blowout Guidance, and Wall Street’s Latest Forecasts

Micron Technology shares hit a record high near $289 during the shortened Christmas Eve session after reporting Q1 2026 revenue of $13.64 billion and strong guidance for Q2. The company projected $18.7 billion in revenue and 68% gross margin for next quarter, citing tight memory supply driven by AI data center demand. Analysts issued upgrades, with Rosenblatt setting a $500 price target.
24 December 2025
···
GE Vernova Stock (NYSE: GEV) News on Dec. 24, 2025: AI Power Demand, Raised 2026–2028 Outlook, and Wall Street’s Latest Targets

GE Vernova Stock (NYSE: GEV) News on Dec. 24, 2025: AI Power Demand, Raised 2026–2028 Outlook, and Wall Street’s Latest Targets

GE Vernova shares traded near $667 on Dec. 24, up 0.9% after a volatile two weeks marked by analyst upgrades and new contracts. The stock has swung sharply this month following raised multi-year guidance and concerns over AI-driven power demand. U.S. markets closed early for Christmas Eve, amplifying price moves amid thin trading.
24 December 2025
···
Rocket Lab (RKLB) Stock News Today: $816M Space Force Contract, Needham Raises Price Target to $90, and 2026 Forecasts

Rocket Lab (RKLB) Stock News Today: $816M Space Force Contract, Needham Raises Price Target to $90, and 2026 Forecasts

Rocket Lab shares slipped modestly on December 24, trading in the mid-$70s after a sharp December rally driven by an $816 million U.S. Space Development Agency contract for 18 satellites. The pullback came during a low-volume, early-close session on Christmas Eve. U.S. equity markets closed at 1 p.m. ET, with normal trading resuming after Christmas. Rocket Lab’s total SDA contract value now exceeds $1.3 billion.
24 December 2025
····
Tesla Stock Today (Dec. 24, 2025): TSLA Near $485 as NHTSA Probe, Delivery Forecasts and Robotaxi Bets Drive the Outlook

Tesla Stock Today (Dec. 24, 2025): TSLA Near $485 as NHTSA Probe, Delivery Forecasts and Robotaxi Bets Drive the Outlook

Tesla shares traded around $485 on Dec. 24, just below the $500 mark after hitting a record high of $498.83 last week. The U.S. NHTSA opened a defect probe into 179,071 Model 3 vehicles over emergency door release concerns. Wall Street analysts trimmed delivery forecasts, citing pressure on core EV sales. Trading volume was lighter due to the holiday-shortened session.
24 December 2025
···
Netflix Stock (NFLX) News and Forecast on Dec. 24, 2025: Warner Bros Deal Financing, Analyst Targets, and What Investors Are Watching

Netflix Stock (NFLX) News and Forecast on Dec. 24, 2025: Warner Bros Deal Financing, Analyst Targets, and What Investors Are Watching

Netflix shares traded at $92.77, down 0.8% as of 9:53 a.m. ET Wednesday, amid a shortened Christmas Eve session. Wall Street focused on Netflix’s $82.7 billion bid to acquire Warner Bros.’ studios and streaming assets, announced Dec. 5. The deal is expected to close in 12–18 months, pending regulatory and shareholder approvals. The NYSE will close early at 1:00 p.m. ET.
24 December 2025
··
Apple Stock (AAPL) News, Forecasts and Analyst Outlook for December 24, 2025: AI “Siri 2.0” Catalyst, App Store Regulation, and What’s Next in 2026

Apple Stock (AAPL) News, Forecasts and Analyst Outlook for December 24, 2025: AI “Siri 2.0” Catalyst, App Store Regulation, and What’s Next in 2026

Apple shares traded near $272 in light volume Wednesday as U.S. markets closed early for Christmas Eve. A federal judge blocked Texas’ app store age-verification law, easing compliance concerns for Apple. The S&P 500 hit a record high Tuesday, with year-end positioning and AI expectations in focus for AAPL.
24 December 2025
··
Novo Nordisk Stock (NVO) in Focus on Dec. 24, 2025: Wegovy Pill Shockwave, Policy Tailwinds, and Analyst Forecasts

Novo Nordisk Stock (NVO) in Focus on Dec. 24, 2025: Wegovy Pill Shockwave, Policy Tailwinds, and Analyst Forecasts

U.S. regulators have approved Novo Nordisk’s oral Wegovy pill for weight management and cardiovascular risk reduction, sending NVO shares higher earlier this week. Analysts are watching pricing and insurance coverage in the U.S., as well as competition in India ahead of 2026 generic launches. The pill is expected to reach U.S. patients in January. NVO stock traded in the low-$50s on Dec. 24.
24 December 2025
···
Strategy Inc Stock MSTR News and Forecasts for December 24, 2025: Cash Reserve Pivot, Bitcoin Pause, and Wall Street Targets

Strategy Inc Stock MSTR News and Forecasts for December 24, 2025: Cash Reserve Pivot, Bitcoin Pause, and Wall Street Targets

Strategy Inc shares traded around $158 on December 24 after the company disclosed it sold 4.54 million shares for $747.8 million and paused Bitcoin purchases, keeping holdings steady. The firm’s U.S. dollar reserves rose to $2.19 billion, up from $1.44 billion earlier in December. Executive Chairman Michael Saylor is promoting a shift toward a broader capital markets platform.
24 December 2025
··
Broadcom (AVGO) Stock News Today, Forecasts and Analysis for Dec. 24, 2025: AI Margins, Tariffs, Insider Moves and Valuation

Broadcom (AVGO) Stock News Today, Forecasts and Analysis for Dec. 24, 2025: AI Margins, Tariffs, Insider Moves and Valuation

Broadcom shares traded near $350 on Dec. 24 amid thin holiday liquidity, following a volatile December driven by strong AI demand and margin concerns. The company projected Q1 revenue of $19.1 billion but warned of a 100 basis point gross margin drop due to lower-margin AI products. Broadcom reported a $73 billion backlog, mostly from five customers. U.S. delayed new China chip tariffs until 2027.
24 December 2025
··
Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next

Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next

Rezolute shares remain under pressure after the company’s December 11, 2025, announcement that its pivotal sunRIZE Phase 3 trial for ersodetug in congenital hyperinsulinism failed to meet primary and key secondary endpoints. The stock trades near $2.42, well below pre-trial levels, following analyst downgrades and investor-law-firm probes. Two serious hypersensitivity reactions were reported in the trial.
24 December 2025
··
Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025

Reviva Pharmaceuticals shares fell to $0.32 on December 24, 2025, after the FDA recommended a second Phase 3 trial for its schizophrenia drug brilaroxazine before a New Drug Application. The company said the new trial, RECOVER-2, could cost $60 million and delay potential approval to late 2028. Reviva plans to start the trial in the first half of 2026, pending financing.
24 December 2025
···
Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth (CGC) Stock on Dec. 24, 2025: Schedule III Executive Order, MTL Cannabis Deal, and the Latest Forecasts

Canopy Growth shares closed at $1.40 on Dec. 23, up 6.06%, after heavy trading and sharp swings throughout December. The volatility followed a Dec. 18 White House executive order directing marijuana rescheduling from Schedule I to III. Trading volume spiked to over 216 million shares on Dec. 18, with implied volatility near 143%. U.S. exchanges operated a shortened session on Dec. 24.
24 December 2025
····
Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Sanofi announced a deal to acquire Dynavax Technologies for $2.2 billion in cash, offering $15.50 per share—a 39% premium to Dynavax’s prior close. DVAX stock jumped about 37% premarket to near the offer price. Dynavax’s board approved the transaction. Closing is expected in Q1 2026, pending regulatory and shareholder approvals.
24 December 2025
···
Lloyds Banking Group (LLOY) Share Price on 24 December 2025: Latest News, 2026 Forecasts, Dividend Outlook and Key Risks

Lloyds Banking Group (LLOY) Share Price on 24 December 2025: Latest News, 2026 Forecasts, Dividend Outlook and Key Risks

Lloyds Banking Group shares traded near 97.5p on December 24, 2025, close to their 52-week high and just below the key £1 mark. Trading volumes were thin ahead of the Christmas break, with the London Stock Exchange running a half-day. The stock’s outlook remains clouded by UK motor finance redress and the impact of Bank of England rate cuts. Lloyds has gained about 80% over the past year.
24 December 2025
··
UOB Stock Price Today (SGX: U11): Shares Close at S$35.03 on Dec 24, 2025 as 2026 Margin Forecasts Take Center Stage

UOB Stock Price Today (SGX: U11): Shares Close at S$35.03 on Dec 24, 2025 as 2026 Margin Forecasts Take Center Stage

UOB shares closed up 0.1% at S$35.03 on Dec 24, outperforming DBS and OCBC as the Straits Times Index slipped 0.06% in thin holiday trading. UOB was the only major Singapore bank to finish higher. The bank’s 3Q net profit fell 72% year-on-year after S$1.36 billion in credit allowances, with management citing exposure to U.S. and Greater China property risks.
24 December 2025
··
DroneShield Limited (ASX:DRO) Stock Today: New $6.2m Asia-Pacific Military Contract, Governance Reset, and 2026 Analyst Forecasts (24 Dec 2025)

DroneShield Limited (ASX:DRO) Stock Today: New $6.2m Asia-Pacific Military Contract, Governance Reset, and 2026 Analyst Forecasts (24 Dec 2025)

DroneShield Limited (ASX:DRO) announced a $6.2 million Asia-Pacific military contract via a reseller, with delivery and payment expected in 2026. The reseller is a subsidiary of a global, publicly listed firm distributing to a major military customer. Shares closed at A$3.29 on December 24 after a volatile session. The company has secured 14 contracts from the same channel over two years, totaling over $48 million.
24 December 2025
···
Northern Star Resources (ASX:NST) Stock: Latest News, Analyst Forecasts and Outlook on 24 December 2025

Northern Star Resources (ASX:NST) Stock: Latest News, Analyst Forecasts and Outlook on 24 December 2025

Northern Star Resources shares traded around A$27.01 on 24 December 2025, up from a previous close of A$26.70, as spot gold hit a record $4,524/oz. The All Ordinaries Gold sub-index reached new highs, with Northern Star rising as much as 1.5% during the session. The company last reported Q1 FY26 gold sales of 381,055 oz at an all-in sustaining cost of A$2,522/oz.
24 December 2025
···
PLS Group Limited Stock (ASX: PLS) Surges Into Christmas Eve Spotlight: Latest News, Forecasts, and Analyst Outlook on 24 December 2025

PLS Group Limited Stock (ASX: PLS) Surges Into Christmas Eve Spotlight: Latest News, Forecasts, and Analyst Outlook on 24 December 2025

PLS Group Limited, formerly Pilbara Minerals, ranked among the most-bought stocks on the ASX 200 in holiday-shortened trading on December 24, 2025, as record metals prices lifted mining shares. The company, now rebranded, owns the Pilgangoora lithium operation in Australia and a major project in Brazil. Demand for PLS surged alongside other miners, according to ABC’s Markets Live.
24 December 2025
··
1 … 3 4 5 6 7 … 42

Stock Market Today

  • West African Resources Posts Strong 2025 Sales and Earnings, Impacting Investment Outlook
    March 21, 2026, 10:10 PM EDT. West African Resources Limited (ASX:WAF) reported a notable rise in full-year 2025 sales to A$1.543 billion and net income to A$473.9 million, driven by increased production and cost controls. Basic earnings per share nearly doubled to A$0.416, highlighting improved shareholder returns. The company reaffirmed its 2025 production guidance targeting up to 360,000 ounces from its Burkina Faso gold operations amid ongoing risks such as power supply and cost inflation. Projections indicate revenue could reach A$2.2 billion by 2028, with earnings rising to A$782.2 million, suggesting a 35% upside to current share prices. However, concentrated country risks and operational challenges remain key considerations for investors assessing WAF's growth prospects.
Go toTop